Would the United States Benefit from a COVID Lockdown? Reassessing the Situation

preprint OA: gold publisher-OA-unknown
🔓 Open OA copy View at publisher
AI-generated summary by claude@2026-07, 2026-07-14

This paper estimates that a two-to-four-week COVID lockdown in the U.S. could save up to 156,000 lives and generate a net benefit of $508 billion.

One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works

Abstract

Though COVID vaccines have become available in United States in December 2020, the speed of vaccinations remains slow. In the meantime, the virus continues to claim thousands of lives every day. I estimate that with the promised rate of vaccinations, if no additional non-pharmaceutical interventions are implemented, 156 thousand more lives will be lost, and the future cost of the pandemic will reach nearly one trillion dollars, or 5% of GDP. I assess whether it is optimal for the United States to follow the lead of many European countries and introduce a nation-wide lockdown. A lockdown would be indeed optimal and, depending on the assumptions, it should last between two and four weeks and will generate a net benefit of up to $508 billion. A lockdown should last even longer and its net benefit could nearly triple if the more transmissible "U.K. variant" of the virus becomes prevalent in the U.S. in the future.

My notes (saved in your browser only)

Citation neighborhood (no data yet)

We don't have any in-corpus citations linked to this paper yet. The paper's references may be in our DB but unresolved to ``paper_id`` (resolution happens at ingest when the cited DOI matches a row we already have). Run the cross-source citation reconcile pass to retry.

Source provenance

europepmc
last seen: 2026-05-19T01:45:01.086888+00:00
unpaywall
last seen: 2026-05-21T05:10:58.409756+00:00
License: publisher-OA-unknown · commercial use NOT OK · attribution required